News

NTI | bio Interim VP Margaret Hamburg Receives Prestigious AAAS Award for Distinguished Career

NTI | bio Interim Vice President and Chair of the NTI | bio Advisory Group Dr. Margaret A. Hamburg is the recipient of the 2022 Philip Hauge Abelson Prize for her distinguished career addressing challenges at the intersection of science, medicine and the public. The American Association for the Advancement of Science (AAAS) announced Hamburg’s selection alongside seven other recipients of awards and prizes given by the AAAS Board of Directors. These annual awards recognize scientists, engineers, authors, journalists, and public servants for their significant contributions to science and the public’s understanding of science. The Philip Hauge Abelson Prize honors a public servant for sustained exceptional contributions to advancing science, or a scientist or engineer whose career has been distinguished for scientific achievement and for other notable services to the scientific community.

Read more about the AAAS awards here.

About Dr. Margaret A. Hamburg

Dr. Margaret A. Hamburg is an internationally recognized leader in public health and medicine, who currently serves as chair of the NTI | bio Advisory Group. She previously served as foreign secretary of the National Academy of Medicine and is a former Commissioner of the U.S. Food and Drug Administration (FDA), having served for almost six years. Before joining FDA, Hamburg was founding vice president and senior scientist at the Nuclear Threat Initiative. Previous government positions include Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Health Commissioner for New York City, and Assistant Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Hamburg recently stepped down from her position as Foreign Secretary of the National Academy of Medicine, the health arm of the National Academy of Sciences, Engineering and Medicine. In her former role, she served as senior advisor on international matters and was the liaison with other Academies of Medicine around the world. She is an elected member of the Council on Foreign Relations and the National Academy of Medicine. Hamburg currently sits on the boards of the Commonwealth Fund, the Simons Foundation, the Urban Institute, the Global Alliance for Vaccines and Immunization, the Parker Institute for Cancer Immunotherapy and the American Museum of Natural History. She is chair of the Joint Coordinating Group for the Coalition for Epidemic Preparedness and Innovation, and a member of the Harvard University Global Advisory Council, the Global Health Scientific Advisory Committee for the Gates Foundation, the Harvard Medical School Board of Fellows, and the World Dementia Council.

Hamburg earned her B.A. from Harvard College, her M.D. from Harvard Medical School and completed her medical residency at Weill Cornell Medical Center. She is the recipient of multiple honorary degrees and numerous awards.

Stay Informed

Sign up for our newsletter to get the latest on nuclear and biological threats.

Sign Up

More News


NTI | bio Champions Effort to Enhance Transparency to Strengthen the Biological Weapons Convention

News

NTI | bio Champions Effort to Enhance Transparency to Strengthen the Biological Weapons Convention

The international community remains unprepared for the potential misuse of modern bioscience and biotechnology tools to develop biological weapons. NTI | bio convened more than 30 experts for a workshop on enhancing transparency for bioscience research and development and bolstering confidence in compliance with the Biological Weapons Convention.



See All News

Close

My Resources